Next 10 |
home / stock / abeo / abeo articles
CLEVELAND, May 28, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced that members of its senior management team wi...
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. ("Abeona"?...
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on Tuesday. The Dow traded up 0.68% to 38,499.41 whi...
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.60% to 38,470.94 ...
BOSTON, April 23, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Abeona Therapeutics, Inc. (NASDAQ:ABEO) for potential securities...
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 0.5% on Tuesday. Following the market opening Tuesday, the Dow tra...
On Monday, Abeona Therapeutics Inc (NASDAQ:ABEO) announced a regulatory update for prademagene zamikeracel (pz-cel).&...
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion ...
U.S. stock futures were slightly higher this morning, with the Dow futures gaining over 20 points on Tuesday. Shares of Calix, Inc. (NYSE:CALX) fel...
News, Short Squeeze, Breakout and More Instantly...
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
CLEVELAND, May 28, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its senior management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. Eastern Time. The Company will a...
BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash runway into 2026 CLEVELAND, May 15, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...